Danaher | DHR - 負債





負債 変化する 日付
Abbott USD 34.05B 20.19B 2026-03
Agilent USD 3.35B 0 2025-12
Align Technology USD 116.04M 1.6M 2026-03
Becton, Dickinson and Co. USD 17.28B 2.26B 2026-03
Bio Techne USD 200M 60M 2026-03
Bio-Rad Laboratories USD 1.38B 7.9M 2026-03
Boston Scientific USD 11.03B 407M 2026-03
Bruker USD 1.67B 371.6M 2026-03
Charles River Laboratories USD 3.06B 485.84M 2026-03
Danaher USD 26.56B 8.07B 2026-06
Dentsply International USD 2.33B 137M 2026-03
Edwards Lifesciences USD 600M 105.4M 2026-03
ESCO Technologies USD 85M 105.71M 2026-06
Fortive USD 3.51B 20.2M 2026-06
Henry Schein USD 3.75B 313M 2026-03
Illumina USD 2.54B 9M 2026-03
Intuitive Surgical USD 0 0 2025-03
IQVIA Holdings USD 16.24B 408M 2026-06
Keysight Technologies USD 2.53B 3M 2026-03
Laboratory Of America USD 7.24B 714.6M 2026-03
Medtronic USD 28.07B 1.03B 2025-12
Mettler Toledo International USD 2.23B 76.47M 2026-03
Myriad Genetics USD 59.3M 19.7M 2025-03
OraSure Technologies USD 782K 465K 2024-06
Quest Diagnostics USD 6.41B 179M 2026-03
Quidel USD 2.87B 40.8M 2026-03
Repligen USD 690.94M 144.36M 2026-06
Revvity USD 3.35B 48.03M 2026-03
Roper Industries USD 10.46B 1.11B 2026-03
Stryker USD 14.19B 32M 2026-06
Thermo Fisher Scientific USD 43.16B 3.78B 2026-03
Waters USD 5.57B 4.08B 2026-03
Zimmer Biomet Holdings USD 7.48B 8M 2026-06